Pulse Biosciences Inc
Research Pulse Biosciences Inc (PLSE) on Bullrun: market cap USD 3.47B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPLSE
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Market capUSD 3.47B
- Financial periodQ2 2026
- RevenueUSD 434.00K
- Net income-USD 24.66M
- Free cash flow-USD 18.80M
- Gross margin37.1%
Valuation Snapshot
latest market cap is USD 3.47B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 350.00K | -USD 72.78M | -USD 54.44M | -54.0% | -1.08 | USD 80.74M | USD 7.53M | USD 80.66M |
| FY2024 | USD 0 | -USD 53.59M | -USD 36.47M | n/a | -0.9 | USD 118.04M | USD 8.90M | USD 114.86M |
| FY2023 | USD 0 | -USD 42.21M | -USD 33.16M | n/a | -1.55 | USD 44.37M | USD 9.14M | USD 44.36M |
| FY2022 | USD 700.00K | -USD 58.51M | -USD 47.41M | -1606.3% | n/a | USD 61.14M | USD 10.45M | -USD 2.25M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 3.47B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 923.67M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 1.15B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 685.62M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 104.87M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 447.56M | n/a | n/a | n/a |
About Pulse Biosciences Inc
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Pulse Biosciences Inc's market cap?
Pulse Biosciences Inc's market capitalization is USD 3.47B.
What does Pulse Biosciences Inc do?
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the.